Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 5
Nutrition (Burbank, Los Angeles County, Calif.), 2008-09, Vol.24 (9), p.832-842
2008
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Weight regain after Roux-en-Y: A significant 20% complication related to PYY
Ist Teil von
  • Nutrition (Burbank, Los Angeles County, Calif.), 2008-09, Vol.24 (9), p.832-842
Ort / Verlag
New York, NY: Elsevier Inc
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
  • Abstract Objective Roux-en-Y gastric bypass (RYGB) produces rapid and dramatic weight loss in very heavy obese patients. Up to 20% cannot sustain their weight loss beyond 2 to 3 y after surgery. Methods To identify putative etiologic factors producing post-RYGB weight regain, a literature survey of metabolic changes in very obese and a review of our diet-induced obese RYGB rat model data was done. Results Weight regain suggests an imbalance in physiologic mechanisms regulating appetite and metabolic rate. Weight regain occurred in 25% of our rats, produced by return to presurgical energy intake levels. The 75% of rats that sustained weight loss secreted a significantly larger amount of peptide YY (PYY) while suppressing leptin secretion; those that failed were unable to develop or sustain a sufficiently large plasma PYY:leptin ratio. Metabolic consequences of this failure included reversal of initial postsurgical increases in peripheral fatty acid oxidation, anorexigenic activity in the hypothalamic arcuate nucleus and paraventricular nucleus, and the expression of uncoupling protein-2 in adipose tissues, and decreases in hepatic lipogenesis, free tri-iodothyronine secretion, expression of orexigenic activity in the arcuate nucleus and paraventricular nucleus, expression of adenosine monophosphate kinase in adipose tissues, skeletal muscle mitochondrial mass, and endocannabinoid content and appetite. Conclusion Weight regain after RYGB occurs in approximately 20% of patients and constitutes a serious complication. Weight regain–promoting consequences are attributed to a failure to sustain elevated plasma PYY concentrations, indicating that combining RYGB with pharmacologic stimulation of PYY secretion in patients after RYGB who exhibit inadequate PYY concentration may increase long-term success of surgical weight reduction in morbidly obese adults.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX